• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Apheresis Market by Applications, Devices & Disposables - Forecasts To 2017 - Product Image Special Offer Sale Banner

Apheresis Market by Applications, Devices & Disposables - Forecasts To 2017

  • ID: 2373021
  • January 2013
  • 195 Pages
  • Markets and Markets
Special Offer Banner
10%
OFF
Offer ends 31st Dec 2014

FEATURED COMPANIES

  • B Braun Melsungen Ag
  • Cerus Corporation
  • Fenwal, Inc
  • Haemonetics Corporation
  • Hemacare Corporation
  • Kaneka Corporation
  • MORE

'Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017'

Apheresis is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components and returns the remaining with or without extracorporeal treatment or replacement of separated component.

This process involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. The global market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

This market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B Braun Melsungen Ag
  • Cerus Corporation
  • Fenwal, Inc
  • Haemonetics Corporation
  • Hemacare Corporation
  • Kaneka Corporation
  • MORE

1 Introduction
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Assumptions

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Blood Shortage & Blood Safety To Increase The Demand For Apheresis Blood
3.3.1.2 Advantage Of Apheresis Collection Over Whole Blood Collection To Boost The Growth
3.3.1.3 Increasing Demand For Plasma Derived Products To Spur The Apheresis Market
3.3.1.4 Increase In Aging Population Demands Growth Of Apheresis
3.3.2 Restraints
3.3.2.1 Lack Of Awareness & Challenges In Donor Recruitment To Restrict The Growth Of Apheresis
3.3.2.2 High Cost Of Apheresis Procedures To Hinder The Acceptability
3.3.3 Opportunities
3.3.3.1 Extending Reach Of Apheresis
3.3.3.2 Untapped Pediatric Segment Can Soon Gain Importance In Apheresis
3.4 Market Share Analysis
3.5 End-User Analysis

4 Global Market, By Procedure
4.1 Introduction
4.2 Automated/Apheresis Blood Collection (Donor Apheresis)
4.3 Therapeutic Apheresis
4.3.1 Neurologic Disorders
4.3.2 Blood Disorders
4.3.3 Renal Disorders
4.3.4 Metabolic Disorders
4.3.5 Other Disorders

5 Global Market, By Product Type
5.1 Introduction
5.2 Devices
5.3 Disposables

6 Global Market, By Technology
6.1 Introduction
6.2 Centrifugation
6.2.1 Driver & Restraint
6.2.1.1 Advantages Offered By Centrifugation Technology Over Membrane Separation
6.2.1.2 Centrifugation Apheresis Process Is Time-Consuming
6.3 Membrane Separation

7 Global Market, By Application
7.1 Introduction
7.2 Plasmapheresis
7.2.1 Drivers
7.2.1.1 Huge Demand For Plasma From Biopharmaceutical Companies
7.2.1.2 New Applications And Opportunities In Developing Countries
7.3 Plateletpheresis
7.4 Erythrocytapheresis
7.5 Leukapheresis
7.6 Others

8 Geographic Analysis
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia
8.5 Row (Rest Of The World)

9 Competitive Landscape
9.1 Introduction
9.2 Mergers & Acquisitions
9.3 Agreements, Partnerships, Collaborations & Joint Ventures 127
9.4 Products Launch
9.5 Expansions
9.6 Other Developments
9.7 Approvals

10 Company Profiles(Overview, Financials, Products & Services, Strategy, & Developments)*
10.1 Asahi Kasei Medical Co., Ltd. (A Subsidiary Of
10.2 B. Braun Melsungen Ag
10.3 Cerus Corporation
10.4 Fenwal, Inc.
10.5 Fresenius Medical Care Ag & Co. Kgaa
10.6 Haemonetics Corporation
10.7 Hemacare Corporation
10.8 Kaneka Corporation
10.9 Kawasumi Laboratories, Inc.
10.1 Medica S.P.A
10.11 Nikkiso Co., Ltd.
10.12 Terumo Bct, Inc.
10.13 Therakos, Inc.
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables

Table 1 Global Market, By Procedure, 2010 – 2017 ($Million)
Table 2 Pediatric Transfusions In U.S. By Blood Centers And Hospitals In 2008 (Thousands Of Units)
Table 3 Global Market, By End-User, 2010 – 2017 ($Million)
Table 4 Blood Banks & Blood Collection Centers Apheresis Market, By Geography, 2010 – 2017 ($Million)
Table 5 Hospitals & Hospital Attached Blood Banks Apheresis Market, By Geography, 2010 – 2017 ($Million)
Table 6 Others Apheresis End-User Market, By Geography,2010 – 2017 ($Million)
Table 7 Global Apheresis (Donor & Therapeutic Apheresis) Market,By Procedure, 2010 – 2017 ($Million)
Table 8 Automated Blood Collection Market, By Geography,2010 – 2017 ($Million)
Table 9 Types Of Therapeutic Apheresis Procedures
Table 10 Therapeutic Apheresis Market, By Geography,2010 – 2017 ($Million)
Table 11 Disease/Disorder Treated By Therapeutic Apheresis
Table 12 Global Therapeutic Apheresis Market, By Disease,2010 - 2017 ($Million)
Table 13 Neurologic Disorders - Therapeutic Apheresis Market,By Geography, 2010 – 2017 ($Million)
Table 14 Blood Disorders - Therapeutic Apheresis Market,By Geography, 2010 - 2017 ($Million)
Table 15 Blood Disorders Therapeutic Apheresis Market,By Diseases, 2010 – 2017 ($Million)
Table 16 Ttp Therapeutic Apheresis Market, By Geography,2010 – 2017 ($Million)
Table 17 Leukemia Therapeutic Apheresis Market, By Geography,2010 – 2017 ($Million)
Table 18 Other Blood Disorder Therapeutic Apheresis Market,By Geography, 2010 – 2017 ($Million)
Table 19 Renal Disorders - Therapeutic Apheresis Market,By Geography, 2010 – 2017 ($Million)
Table 20 Metabolic Disorders - Therapeutic Apheresis Market,By Geography, 2010 – 2017 ($Million)
Table 21 Other Disorders - Therapeutic Apheresis Market,By Geography, 2010 – 2017 ($Million)
Table 22 Global Market, By Product Type,2010 – 2017 ($Million)
Table 23 Apheresis Devices Market, By Geography,2010 – 2017 ($Million)
Table 24 Apheresis Devices Market, By Applications,2010 - 2017 ($Million)
Table 25 Apheresis Devices/Systems In The Market
Table 26 Apheresis Disposables Market, By Geography,2010 – 2017 ($Million)
Table 27 Global Apheresis Disposables Market, By Application,2010 – 2017 ($Million)
Table 28 Global Market, By Technology,2010 – 2017 ($Million)
Table 29 Density Of Blood Components (Kg/L)
Table 30 Centrifugation Technology Based Apheresis Devices
Table 31 Centrifugation-Based Apheresis Market, By Geography,2010 – 2017 ($Million)
Table 32 North America: Centrifugation Apheresis Market,By Country, 2010 – 2017 ($Million)
Table 33 Europe: Centrifugation Apheresis Market, By Country,2010 – 2017 ($Million)
Table 34 Asia: Centrifugation Apheresis Market, By Country,2010 – 2017 ($Million)
Table 35 Row: Centrifugation Apheresis Market, By Country,2010 – 2017 ($Million)
Table 36 Size Of Blood Components
Table 37 Membrane Separation Apheresis Devices
Table 38 Membrane Separation-Based Apheresis Market, By Geography, 2010 – 2017 ($Million)
Table 39 North America: Membrane Separation Apheresis Market,By Country, 2010 – 2017 ($Million)
Table 40 Europe: Membrane Separation Apheresis Market,By Country, 2010 – 2017 ($Million)
Table 41 Asia: Membrane Separation Apheresis Market, By Country, 2010 – 2017 ($Million)
Table 42 Row: Membrane Separation Apheresis Market, By Country, 2010 – 2017 ($Million)
Table 43 Global Market, By Application,2010 - 2017 ($Million)
Table 44 Plasma Collection In United States From 2005 To 2010 (Thousand Liters)
Table 45 Plasmapheresis Market, By Geography, 2010 - 2017 ($Million)
Table 46 Global Plasmapheresis Market, By Procedure,2010 - 2017 ($Million)
Table 47 Plateletpheresis Market, By Geography, 2010 - 2017 ($Million)
Table 48 Global Plateletpheresis Market, By Procedure,2010 - 2017 ($Million)
Table 49 Erythrocytapheresis Market, By Geography,2010 - 2017 ($Million)
Table 50 Global Erythrocytapheresis Market, By Procedure,2010 - 2017 ($Million)
Table 51 Leukapheresis Market, By Geography, 2010 - 2017 ($Million)
Table 52 Global Leukapheresis Market, By Procedure,2010 - 2017 ($Million)
Table 53 Other Apheresis Application Market, By Geography,2010 - 2017 ($Million)
Table 54 Apheresis Market, By Geography, 2010 - 2017 ($Million)
Table 55 North America: Apheresis Market, By Country,2010 - 2017 ($Million)
Table 56 North America: Market, By Procedure,2010 - 2017 ($Million)
Table 57 North America: Market, By Application,2010 - 2017 ($Million)
Table 58 North America: Market, By Technology,2010 - 2017 ($Million)
Table 59 North America: Market, By Product Type,2010 - 2017 ($Million)
Table 60 North America: Market, By End-User,2010 - 2017 ($Million)
Table 61 Europe: Apheresis Market, By Country, 2010 - 2017 ($Million)
Table 62 Europe: Market, By Procedure,2010 - 2017 ($Million)
Table 63 Europe: Market, By Application,2010 - 2017 ($Million)
Table 64 Europe: Market, By Technology,2010 - 2017 ($Million)
Table 65 Europe: Market, By Product Type,2010 – 2017 ($Million)
Table 66 Europe: Market, By End-User, 2010 - 2017 ($Million)
Table 67 Asia: Apheresis Market, By Country, 2010 - 2017 ($Million)
Table 68 Asia: Market, By Procedure, 2010 - 2017 ($Million)
Table 69 Asia: Market, By Application, 2010 - 2017 ($Million)
Table 70 Asia: Market, By Technology, 2010 - 2017 ($Million)
Table 71 Asia: Market, By Product Type,2010 - 2017 ($Million)
Table 72 Asia: Market, By End-User, 2010 - 2017 ($Million)
Table 73 Row: Apheresis Market, By Region, 2010 - 2017 ($Million)
Table 74 Row: Market, By Procedure, 2010 - 2017 ($Million)
Table 75 Row: Market, By Application, 2010 - 2017 ($Million)
Table 76 Row: Market, By Technology, 2010 - 2017 ($Million)
Table 77 Row: Market, By Product Type,2010 - 2017 ($Million)
Table 78 Row: Market, By End-User, 2010 - 2017 ($Million)
Table 79 Mergers & Acquisitions, 2010 – 2012
Table 80 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 – 2012
Table 81 Products Launch, 2010 – 2012
Table 82 Expansions, 2010 –2012
Table 83 Other Developments, 2010 – 2012
Table 84 Approvals, 2010 – 2012
Table 85 Asahi Kasei Medical Co., Ltd: Total Revenue And R&D Expenditure, 2009 – 2011 ($Million)
Table 86 B. Braun Melsungen Ag: Total Revenue And R&D Expenditure, 2009 – 2011 ($Million)
Table 87 B. Braun Melsungen Ag: Total Revenue, By Segment,2009 – 2011 ($Million)
Table 88 B. Braun Melsungen Ag: Total Revenue, By Geography,2009 – 2011 ($Million)
Table 89 Cerus Corporation: Total Revenue And R&D Expenditure,2009 – 2011 ($Million)
Table 90 Fresenius Medical Care Ag: Total Revenue And R&D Expenditure, 2009 – 2011 ($Million)
Table 91 Fresenius Medical Care Ag: Total Revenue, By Segment,2009 – 2011 ($Million)
Table 92 Fresenius Medical Care Ag: Total Revenue, By Geography, 2009 – 2011 ($Million)
Table 93 Haemonetics: Total Revenue And R&D Expenditure,2009 – 2011 ($Million)
Table 94 Haemonetics: Total Revenue, By Segment,2009 – 2011 ($Million)
Table 95 Haemonetics: Disposables Revenue, By Product Type,2009 – 2011 ($Million)
Table 96 Haemonetics: Total Revenue, By Geography,2009 – 2011 ($Million)
Table 97 Kaneka Corporation: Total Revenue, By Segment,2010 – 2012 ($Million)
Table 98 Kawasumi Laboratories, Inc.: Total Revenue And R&D Expenditure, 2008 – 2010 ($Million)
Table 99 Kawasumi Laboratories, Inc.: Total Revenue, By Segment,2008 – 2010 ($Million)
Table 100 Nikkiso Co., Ltd: Total Revenue And R&D Expenditure,2010 – 2012 ($Million)
Table 101 Nikkiso Co., Ltd: Total Revenue, By Geography,2010 – 2012 ($Million)

List Of Figures

Figure 1 Global Market, By Application, 2012
Figure 2 Blood Industry Value Chain
Figure 3 Apheresis Market Segmentation
Figure 4 Apheresis Market - Drivers & Restraints
Figure 5 Global Market Share Analysis, By Key Players, 2011
Figure 6 Key Growth Strategies, 2010 – 2012

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B Braun Melsungen Ag
  • Cerus Corporation
  • Fenwal, Inc
  • Haemonetics Corporation
  • Hemacare Corporation
  • Kaneka Corporation
  • MORE

Apheresis is a process wherein blood is collected and separated into different components, leveraging on centrifugation and membrane separation technology. The global market is valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017, growing at a CAGR of 11% from 2012 to 2017.

The market studied in this report is segmented by procedure, application, technology, product type, and end-user. Based on the rationale of the apheresis procedure, the market is segmented as automated blood collection (donor) and therapeutic apheresis. Automated blood collection accounts for the largest share of the global market, by procedure, in 2012. The application market is divided into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis and others, while technology market is classified as centrifugation & membrane separation/filtration in which the former leads the market in 2012. This share can be attributed to the use of centrifugation apheresis devices, mostly by blood banks for collection, and for therapeutics as well due to the advantages offered by centrifugation technology over membrane separation. Centrifugation is used for the apheresis of any blood component whereas the use of membrane separation is limited to plasma exchange. The product types used in this market are majorly classified as devices and disposables.

Increasing blood shortage, advantages of apheresis collection over whole blood and increasing demand for plasma from biopharmaceutical companies are the major drivers that are slated to propel this market. However, donor recruitment and high cost of the apheresis are the major challenges for the growth. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with large population.

The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.

Note: Product cover images may vary from those shown

- Asahi Kasei Medical Co, Ltd
- B Braun Melsungen Ag
- Cerus Corporation
- Fenwal, Inc
- Fresenius Medical Care Ag & Co Kgaa
- Haemonetics Corporation
- Hemacare Corporation
- Kaneka Corporation
- Kawasumi Laboratories, Inc
- Medica SPA
- Nikkiso Co, Ltd
- Terumo Bct, Inc
- Therakos, Inc

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos